-
August 24, 2021 Top 5 Catalysts for Psychedelic Stocks In The Second Half of 2021 (MNMD,CMPS,ATAI,TRYP, CYBN & MORE)What are top 5 catalysts for psychedelic stocks in the second half of 2021? Stay...
-
August 17, 2021 MindMed’s Q2 Earnings Call: What does the future hold for MNMD/ MMED?Check out atai Life Sciences' earnings call: https://www.youtube.com/watch?v=lkE3EmU0o_w What's up psychedelic stocks investors?!? Today marked...
-
August 16, 2021 atai Life Sciences Q2 Conference Call and Questions & Answer Period: BIG NEWS for Psychedelic StocksWhat's up psychedelic stocks investors?!? Today marked atai Life Science's (Nasdaq: atai) first-ever conference call,...
-
August 15, 2021 MindMed Financial Results & Business Update Q2 2021 ( Where Does MNMD/MMED Go From Here?)MindMed's Financial Results & Business Update for Q2 2021 are out! In this episode, we'll...
-
August 13, 2021 Mydecine Joins the BIG LEAGUES! MYCO + Johns Hopkins to treat smoking addiction with MAGIC MUSHROOMSMydecine (OTC: MYCOF, NEO: MYCO) is an aspiring psychedelics medicine company that aims to use...
-
August 9, 2021 NEW MindMed teaming up With Pfizer, J&J and Johns Hopkins on Digital Medicines? (MNMD, PFE, JNJ)As technological change revolutionizes medicine and healthcare, how do we ensure that no-one, particularly members...
-
August 5, 2021 Meet MindMed’s Interim CEO: Robert Barrow | My First Impressions & CommentsMindMed's Interim CEO, Robert Barrow, has not made as many public appearances as opposed to...
-
July 30, 2021 MindMed Launches DMT Clinical Trial (Joe Rogan Must Be Excited for MNMD)MindMed Launches DMT Clinical Trial! Joe Rogan must be excited! In this episode, we'll discuss...
-
July 27, 2021 Will MindMed Partner With Johnson & Johnson for 18MC? ( MNMD & J&J In the Speculation Zone)What's up Psychedelic Investors? We all know that MindMed (MNMD / MMED) has been talking...
-
July 25, 2021 Field Trip Uplists to Nasdaq | Cybin to NYSE | Mydecine MDMA Patent: Big Week For Psychedelic StocksBig Week For Psychedelic Stocks: Field Trip Uplists to Nasdaq, Cybin Uplists to NYSE &...